ACER THERAPEUTICS INC. Deferred Offering Costs
ACER THERAPEUTICS INC. had Deferred Offering Costs of $408.00 thousand as of 2022-12-31, per its 10-Q filed 2023-11-20.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2023-11-20
- 2022-12-31: Deferred Offering Costs $408.00K.
- 2014-09-30: Deferred Offering Costs $48.67K.
- 2014-06-30: Deferred Offering Costs $103.64K.
- 2013-12-31: Deferred Offering Costs $103.64K.
| Period end | Deferred Offering Costs |
|---|---|
| 2022-12-31 | $408.00K 10-Q · filed 2023-11-20 |
| 2014-09-30 | $48.67K 10-Q · filed 2014-11-06 |
| 2014-06-30 | $103.64K 10-Q · filed 2014-08-14 |
| 2013-12-31 | $103.64K 10-K · filed 2015-02-23 |